StockNews.com upgraded shares of Clorox (NYSE:CLX – Free Report) from a hold rating to a buy rating in a research note published on Saturday.
Several other equities analysts have also recently commented on CLX. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Evercore ISI cut their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Citigroup increased their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Barclays lifted their target price on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. Finally, Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and raised their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $155.38.
View Our Latest Stock Analysis on CLX
Clorox Stock Performance
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period last year, the business earned $0.49 earnings per share. The business’s revenue for the quarter was up 27.0% on a year-over-year basis. On average, analysts expect that Clorox will post 6.85 EPS for the current year.
Clorox Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.02%. Clorox’s payout ratio is currently 170.03%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CLX. Prospera Private Wealth LLC purchased a new stake in Clorox during the 3rd quarter worth $27,000. Continuum Advisory LLC boosted its stake in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the last quarter. Innealta Capital LLC acquired a new position in Clorox in the second quarter worth about $30,000. Trifecta Capital Advisors LLC boosted its holdings in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the period. Finally, Quarry LP grew its holdings in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- The 3 Best Fintech Stocks to Buy Now
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Micron: Why Now Is the Time to Be Brave
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.